Evidence map›Paper›PMID 21266850›Full record

ArticleIslets

A novel fluorescence imaging approach for comparative measurements of pancreatic islet function in vitro.

Kathryn L Corbin, Thomas E Hall, Ruth Haile, Craig S Nunemaker

Abstract readComparative StudyEvaluation StudyValidation Study
In one paragraph

Article in Islets. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2013
    Article
  17. Review
  18. Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathryn L CorbinDepartment of Medicine, Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA, USA.
Thomas E Hall
Ruth Haile
Craig S Nunemaker

Funding

PILOT--PILOT/FEASIBILITY PROGRAMP30DK063609 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BARRETT, EUGENE JOSEPH · 2003 to 2007
$5.7M
Assessing and Improving Pancreatic Islet Viability and FunctionK01DK081621 · NIDDK · UNIVERSITY OF VIRGINIA · PI NUNEMAKER, CRAIG S · 2008 to 2010
$324k
NIDDK NIH HHS 1K01 DK081621NIDDK NIH HHS DK063609NIDDK NIH HHS K01 DK081621NIDDK NIH HHS P30 DK063609
6 · The paper itself

Abstract

Pancreatic islet dysfunction is a key element in the development of type 2 diabetes. Determining possible early warning signs of dysfunction is thus important to determining the underlying causes of diabetes. We describe an improved fluorescent imaging approach to detect potential islet dysfunction. Using Cell Tracker Red (CTR, a mildly thiol-reactive fluorescent probe) to positively label particular islets, we measured intracellular free calcium with fura-2 AM in both CTR-labeled and unlabeled sets of pancreatic islets simultaneously in vitro. This approach enhances sensitivity by controlling for differences in background fluorescence, temperature, and perifusion dynamics. We confirmed that 200 nM CTR produced no spectral overlap with fura-2 and no significant physiological effects in selective tests of islet function. To demonstrate the utility of dual-labeling, we compared untreated islets with islets pretreated with low-dose pro-inflammatory cytokines (IL-6 + IL-1B) to induce mild dysfunction. We alternated CTR-labeling between control and test islets and identified consistent reductions in the amplitude and trajectory of glucose-stimulated calcium responses (GSCa) among cytokine-treated islets that were independent of labeling. Observations were verified using a MATLAB program specifically designed to identify key features in the GSCa. Our findings thus demonstrate the utility of CTR-labeling in identifying islet dysfunction and propose that this technique can be adapted for other cells and tissues.

Indexed as

AnimalsCalciumCells, CulturedCell TrackingCytokinesDose-Response Relationship, DrugFluorescent DyesFura-2GlucoseIslets of LangerhansLuminescent MeasurementsMaleMiceMicroscopy, FluorescenceCalciumCytokinesFluorescent DyesFura-2Glucose

Identifiers

PMID21266850
PMCPMC3060435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.